Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 3 Aminobutyric Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108866028B details a mutant amino lyase for producing (R)-3-aminobutyric acid. This biocatalytic route offers superior stereoselectivity and cost efficiency for Dolutegravir intermediates.